Byrna Technologies, Inc. (BYRN)
NASDAQIndustrialsAerospace & DefenseSnapshot 2026-10-29
$4.76+2.37%
Close 2026-10-29 · 1-day change
NASDAQIndustrialsAerospace & DefenseSnapshot 2026-10-29
Research Workspace
Put BYRN beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Aerospace & Defense is in expansion. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Improve gross and operating margins in fiscal 2026: Comparison needs review.
View ThesisRevenue is contracting — down about 13% over the past year.
View GrowthManagement screens weak on earnings delivery, margins, market reaction to earnings.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is highly volatile — it swings about 2% on a typical day and fell roughly 84% in its worst 12-month stretch.
View RiskBYRN’s case rests on restoring demand while reducing inventory and improving working capital. That claim faces sharply falling revenue, despite a recent quarterly earnings beat. Q3 FY2026 revenue fell 46% year over year; reported GAAP earnings beat consensus. BYRN trades at 1.1× sales versus the 3.0× peer median. Expectations look modest versus our view, though the peer comparison may overstate cheapness. Weak demand threatens fiscal 2026 margin improvement; our model puts next-quarter miss probability near 41%. The primary margin pillar needs review because its comparison is unverified. Peer multiples imply a price about 39% above where it trades; the thesis is on watch. This read is provisional.
Trailing returns as of 2026-10-29. BYRN is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 3 analysts currently covering BYRN (as of Oct 2026).
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
Continue this research
Compare BYRN with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| BYRN Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 3 valuation methods, at three horizons. As of 2026-10-29. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Aerospace & Defense — fair value, gap to price, and forward P/E.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Compare the value case
Put BYRN next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Threatens: Margin improvement in fiscal 2026
Weak demand impacts margin improvement plans for fiscal 2026.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-29. EPS is implied from price ÷ P/E. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
TTM earnings are negative. P/E-based methods drop out and the estimate leans on sales- and cash-flow-based methods. A data condition, not a forward call.
Significant stock decline raises concerns about company viability.
Threatens: Margin improvement in fiscal 2026
Weak demand threatens margin improvement objectives.
Advances: Reduce inventory and improve working capital efficiency
Targets inventory decline aligns with working capital efficiency.
Threatens: Margin improvement in fiscal 2026
Q3 revenue miss impacts margin improvement objective.
